HOOKIPA Pharma Inc.
HOOK
$0.825
-$0.0255-3.00%
| Weiss Ratings | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.84 | |||
| Price History | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -31.25% | |||
| 30-Day Total Return | -53.13% | |||
| 60-Day Total Return | -55.65% | |||
| 90-Day Total Return | -61.63% | |||
| Year to Date Total Return | -57.69% | |||
| 1-Year Total Return | -89.05% | |||
| 2-Year Total Return | -88.33% | |||
| 3-Year Total Return | -96.05% | |||
| 5-Year Total Return | -99.01% | |||
| 52-Week High % Change | -92.14% | |||
| 52-Week Low % Change | 1.21% | |||
| Price | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.50 | |||
| 52-Week Low Price | $0.82 | |||
| 52-Week Low Price (Date) | Apr 03, 2025 | |||
| 52-Week High Price (Date) | May 23, 2024 | |||
| Valuation | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.35M | |||
| Enterprise Value | -28.46M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.52 | |||
| Earnings Per Share Growth | -60.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.24 | |||
| Price/Book (Q) | 0.20 | |||
| Enterprise Value/Revenue (TTM) | -0.65 | |||
| Price | $0.83 | |||
| Enterprise Value/EBITDA (TTM) | 0.68 | |||
| Enterprise Value/EBIT | 0.64 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 12.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 431 890 6360 | |||
| Address | 350 Fifth Avenue New York, NY 10118 | |||
| Website | www.hookipapharma.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -101.91% | |||
| Profit Margin | -98.99% | |||
| Management Effectiveness | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -22.96% | |||
| Return on Equity | -- | |||
| Income Statement | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 43.95M | |||
| Total Revenue (TTM) | 43.95M | |||
| Revenue Per Share | $3.50 | |||
| Gross Profit (TTM) | -3.59M | |||
| EBITDA (TTM) | -42.03M | |||
| EBIT (TTM) | -44.79M | |||
| Net Income (TTM) | -43.50M | |||
| Net Income Avl. to Common (TTM) | -43.50M | |||
| Total Revenue Growth (Q YOY) | -81.72% | |||
| Earnings Growth (Q YOY) | -0.53% | |||
| EPS Diluted (TTM) | -3.52 | |||
| EPS Diluted Growth (Q YOY) | 9.56% | |||
| Balance Sheet | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 39.68M | |||
| Cash Per Share (Q) | $3.16 | |||
| Total Current Assets (Q) | 80.67M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 51.21M | |||
| Current Ratio (Q) | 3.272 | |||
| Book Value Per Share (Q) | $4.08 | |||
| Total Assets (Q) | 82.55M | |||
| Total Current Liabilities (Q) | 24.65M | |||
| Total Debt (Q) | 875.00K | |||
| Total Liabilities (Q) | 31.33M | |||
| Total Common Equity (Q) | 51.21M | |||
| Cash Flow | HOOK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -194.00K | |||
| Cash from Financing (TTM) | -1.28M | |||
| Net Change in Cash (TTM) | -77.64M | |||
| Levered Free Cash Flow (TTM) | -49.51M | |||
| Cash from Operations (TTM) | -76.98M | |||
